News

After the BioFIT Steering Committee meeting last month and the interesting exchanges that followed, this year’s preliminary topics have finally been decided. Focusing on entrepreneurship in Life Sciences, this year’s programme includes:

• Lessons learned: Do’s & don’ts from seasoned entrepreneurs
• What is the best background for an academic spin-off CEO: science or industry?
• How can industry and investor incubating models accelerate research translation?
• Are universities a short-term or long term partner for spin-offs?

View the conference programme

Would you like to:

• Share your experience, opinions and knowledge with our audience?
• Present your ideas with our panel?

Apply to be a BioFIT speaker! Contact us

Roche signs a €900M deal with Blueprint Medicines

Roche (Switzerland), leader in cancer therapies, has been redirecting its efforts towards immuno-oncology and has picked 5 candidates from Blueprint Medicines (Boston, US) to complement its leading oncology pipeline.
Blueprint Medicines will receive €40M upfront to collaborate on the development of 5 of its preclinical candidates. Depending on how these small molecule therapies perform in trials, Blueprint could be aiming at over €850M in milestones and licenses.

Source : La Biotech.eu 

AstraZeneca and Genentech put pen on paper and bankroll to finance PatientsLikeMe study on lung cancer

AstraZeneca and Genentech (a member of the Roche Group) have agreed to finance a study of lung cancer patients that will analyze PatientsLikeMe’s patient-reported outcomes alongside traditional forms of data. The project is designed to assess the value of giving researchers a broader overview of factors that can affect health outcomes.

Source : FierceBiotechIT

Cellectis and MabQuest announce immunotherapy partnership

Cellectis (France) and MabQuest announced that they have entered into a research collaboration and license agreement pertaining to the development of a new class of monoclonal antibodies targeting PD-1. These anti-PD-1 mAbs have potential uses for multiple indications in immunotherapy, including notably treatments for a variety of cancers.

Source : BusinessWire

Johnson & Johnson Innovation launches JLINX: A new company incubation model 

Located at the Janssen Campus in Belgium, JLINX will offer scientists and entrepreneurs access to venture funding, state-of-the-art facilities and R&D expertise. JLINX is designed to accelerate early-stage transformative innovation, including an emphasis on the human microbiome as well as broader life-science research.

Source : BusinessWire

We are honored to count among our Supporters for BioFIT 2016: Asebio, Atlanpole Biotherapies, BIA, Biocat, Bionow, BioPartner, Danish Diabetes Academy, Innoget, MediWales, One Nucleus…

Discover the 2016 Supporters here.

As these organizations, become a Supporter of BioFIT and:

• Increase your visibility among 1,300 Life Sciences leading actors
• Get a free pass to attend the event
• Offer your members an incredible 25% discount to attend the event
• …

Contact us to discover all the other benefits!

It’s time to sign up!

Early Bird

The arrival of spring season reminds us that the Early Bird is still running! It’s now time to sign up and benefit from 20% off on BioFIT regular registration fees.

Register now and enjoy the Early Bird offer!

Boost your visibility

With a limited number of stands, do not miss the opportunity to enhance your visibility at an international scale and get identified as a key innovative actor in Life Sciences.

Book your booth now and benefit from the best location in BioFIT exhibition area!

The Pharma Logistics Club organises a lunch-debate on March 15th (Cité des Echanges in Marcq-en-Baroeul) around logistics issues of health products.

During this lunch debate, Etienne Vervaecke, Eurasanté, Nicolas De Clerck, Club logistique et transport
Pascale Percherin, LFB will present their organisations and share their experience with the participants.

This conference will also be an opportunity to present BioFIT to this new audience.

The Pharma Logistics Club (PLC) is a professional association with 50 members including a dozen of health institutions. Its purpose is to facilitate relationships between professionals in the supply chain, laboratories, freight forwarders… in the health sector. PLC organises lunch debates, site visits, working committees and regular meetings to allow to cross its audiences.

Dear BioFITers,

After BioFIT Steering Committee’s meeting last month and the heated debates that followed, this year’s preliminary topics are finally acted upon:

This year’s plenary session will tackle Innovation in Europe, and each conference track will feature round tables, case studies and expert forums to discuss our audience’s concerns.

Focused on best practices collaborative research, Track 1 will put forward the analysis of innovation hubs, the mindset and method correlations in academia/industry collaborations and how to accelarate the deal-making process.

Tackling licensing and tech transfer issues, Track 2 will emphasize topics related to the spin-out process from the university, how to identify the right CEO for an academic spin-off and how to improve dialogue with industry in order to accelerate the translation of innovation to market.

In a challenging environment for financing early stage innovation, Track 3 topics will discuss universities involvement in new venture funds, tips & tricks to spark VCs interest, and the European seed capital market.

What a nice teaser, we can’t wait to discover the official preliminary conference program, and are looking forward to meeting you in Lille!

We are honored to count among our Media Partners for BioFIT 2016: Actulabo, GIT Laboratory Journal Europe, Global Data, Innovation Review, Iptechex, La Gazette du Laboratoire…

Like them, become a Media Partner of BioFIT and:

• Increase your visibility among 1,300 Life Sciences leading actors
• Get a free pass to attend the event
• Benefit from the opportunity to have your magazine displayed during the event
• Schedule interviews with the Steering Committee Members and/or the participants

You are a media specialized in Life Sciences, Biotechnology or Pharmaceutical Industry?

Contact us to become a Media Partner

We were pleased to welcome Philips during this Meeting Day organized by Eurasanté.

This Philips meeting day was an opportunity to discover Philips activities and the company’s collaboration strategy.

B to B meetings with Philips representatives were scheduled and discussions were also held between Philips, industrial stakeholders and researchers around potential partnerships.

Hope you enjoyed this moment and had fruitful meetings!

 

 

We are honored to count INPI as our new BioFIT 2016 Sponsor

INPI (National Institute for Intellectual Property) is the national intellectual property office of France, in charge of patents, trademarks and industrial design rights.

Thank you to INPI for joining BioFIT 2016 as a Bronze Sponsor!

Discover the sponsors that have already confirmed their involvement in BioFIT 2016

Interested in becoming a BioFIT 2016 Sponsor? Please contact us and discover our sponsoring packages!

 

The BioFIT Steering Committee members are our key ambassadors, supporting us at every step of the way. They enable us to propose the best in early stage Life Sciences innovation by designing the content of the conference program, identifying high-level speakers and helping us to set-up new meeting opportunities at BioFIT.

Five Life Sciences experts have joined BioFIT’s Steering Committee this year:

• Haude Costa who represents France Biotech, the Association for French companies in the Life Sciences sector and their partners. Its aim is to contribute to domestic growth in this innovative industry and to support France’s leadership role within the European Life Sciences community.
• Barbara Freischem who represents EBE – European Biopharmaceutical Enterprises, Europe’s expert voice for emerging biosciences and technologies, the leading platform for health innovation ecosystems.
• Sarah Holland who represents Sanofi, and Sabrina Lesage who represents Pfizer, two of the world’s leading innovative biopharmaceutical companies.
• Sara Nunez-Garcia who represents Sofinnova Partners, an investment firm focusing on ambitious Life Sciences projects in biopharmaceutical, medical devices and industrial biotechnology. The company also invests in game-changing technologies and projects which could revolutionize these industries and address tomorrow’s challenges.

Discover the fullest list of Steering Committee members